申请人:Janssen Pharmaceutica, N.V.
公开号:US04200641A1
公开(公告)日:1980-04-29
Novel 1-[(heterocyclyl)alkyl]-4-diarylmethoxy piperidine derivatives are disclosed having the formula ##STR1## where n is 2-6, Ar.sup.1 and Ar.sup.2 are aryl and B is a substituted benzimidazolyl radical. These compounds are useful for their antianaphylactic and antihistaminic properties. Specific claimed compounds are 1-3-[4-(diphenylmethoxy)-1-piperidinyl]-propyl}-1,3-dihydro-2H-benzimidaz ol-2-one, 1-2-[4-(diphenylmethoxy)-1-piperidinyl]ethyl}1-, 3-dihydro-2H-benzimidazol-2-one, and 1-4-[4-(diphenylmethoxy)-1-piperidinyl]butyl}-1,3-dihydro-2H-benzimidazol -2-one.
披露了具有以下式子的Novel 1-[(杂环基)烷基]-4-二芳基甲氧基哌啶衍生物:##STR1## 其中n为2-6,Ar.sup.1和Ar.sup.2为芳基,B为取代苯并咪唑基基团。这些化合物因其抗过敏和抗组胺作用而有用。特定的声称化合物为1-3-[4-(二苯甲氧基)-1-哌啶基]-丙基}-1,3-二氢-2H-苯并咪唑-2-酮,1-2-[4-(二苯甲氧基)-1-哌啶基]乙基}1-, 3-二氢-2H-苯并咪唑-2-酮,以及1-4-[4-(二苯甲氧基)-1-哌啶基]丁基}-1,3-二氢-2H-苯并咪唑-2-酮。